Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) Meeting Abstract


Authors: Hodi, F. S.; Ribas, A.; Daud, A.; Hamid, O.; Robert, C.; Kefford, R.; Hwu, W. J.; Gangadhar, T. C.; Joshua, A. M.; Hersey, P.; Weber, J.; Joseph, R. W.; Zarour, H.; Dronca, R.; Gammage, L.; Hille, D.; Xue, D.; Kang, S. P.; Chun, P.; Ebbinghaus, S. W.; Perrone, A.; Wolchok, J. D.
Abstract Title: Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
Meeting Title: 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 2
Issue: Suppl. 3
Meeting Dates: 2014 Nov 6-9
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2014-11-06
Language: English
DOI: 10.1186/2051-1426-2-S3-P103
PROVIDER: manual
PMCID: PMC4288385
Notes: Meeting Abstract: P103
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
Related MSK Work